LEP and fatty liver disease: In contrast, significant reductions in blood lipid and leptin levels of about 30% were observed in mice given rcREG3A which is consistent with the results obtained in ob/ob mice, as well as a trend toward reduced hepatic steatosis (Fig. 5d–f).